Atovaquone( BW 566C | BW 556C-80 )

Catalog No. M16808 CAS No. 95233-18-4

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Atovaquone
Note

Research use only, not for human use.
Brief Description

Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
Description

Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
In Vitro

——
In Vivo

Animal Model:ICSBP?/??mice infected with 10 cysts of the ME49 strain of?T. gondii Dosage:100 mg/kg Administration:Oral administration Result:Improved mice survival rate to 22 days compared to vehicle.
Synonyms

BW 566C | BW 556C-80
Pathway

Metabolic Enzyme/Protease
Target

Dehydrogenase
Recptor

DHODH| Cytochrome b
Research Area

Infection
Indication

——

CAS Number

95233-18-4
Formula Weight

366.84
Molecular Formula

C22H19ClO3
Purity

>98% (HPLC)
Solubility

DMSO: 5 mg/mL (13.62 mM)
SMILES

O=C1C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)=C(O)C(C4=C1C=CC=C4)=O
Chemical Name

trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione

1.Winter RW, et al. Exp Parasitol. 2008 Apr; 118(4):487-97.

Calculator

molnova catalog